Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Depemokimab as Add-on Maintenance Treatment in Children With Severe Asthma
NCT07671001Phase 3Recruiting
- Sponsor
- GSK
- Start
- Jun 2026
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
A Phase 3 trial of depemokimab in asthma, sponsored by GSK. Started Jun 2026; status: recruiting.
02
Drugs
depemokimab
03
Conditions
asthma
Beyond the preview
Go deeper on NCT07671001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07671001.